People's Hospital of Hunan Province | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria	Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia	Recruiting	Phase 2	2026-09-04		NCT07512596
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer	HER2-positive Advanced Breast Cancer	Recruiting	Phase 3	2026-06-03		NCT07047365
Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)	Metastatic Pancreatic Ductal Adenocarcinoma	Recruiting	Phase 3	2026-05-29		NCT07165951
Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Not yet recruiting	Phase 3	2025-09-23		NCT07187960
Interventional Left Ventricular Assist System for PCI in CHIP Patients	High-Risk Percutaneous Coronary Intervention (High-risk PCI); Left Ventricular Assist Devices	Recruiting	Not applicable	2025-08-26		NCT07053618
A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 3	2025-08-14		NCT06387069